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Abstract
Background: To date, it is unclear if consumer wearable activity trackers (CWATs), with or without behaviour multi-
component strategies, effectively improve adherence to physical activity and health outcomes under free living
conditions in populations with chronic diseases. Therefore, we systematically evaluated the efficacy of CWAT-based
interventions to promote physical activity levels and cardiometabolic health in populations with chronic diseases.
Methods: Randomised controlled trials were collected from five bibliographic databases (PubMed, Embase, Web of
Science, The Cochrane Central Register of Controlled Trials and CINAHL). Studies were eligible for inclusion if they
evaluated a CWAT-based counselling intervention versus control intervention among patients with chronic
respiratory diseases, type 2 diabetes mellitus, cardiovascular diseases, overweight/obesity, cognitive disorders, or
sedentary older adults. Data were pooled using a random-effects model.
Results: After deduplication 8147 were identified of which 35 studies met inclusion criteria (chronic respiratory
diseases: 7, type 2 diabetes mellitus: 12, cardiovascular diseases: 6, overweight/obesity: 3, cognitive disorders: 1,
sedentary older adults: 6). Compared to control groups, CWAT-based interventions significantly increased physical
activity by 2123 steps per day (95% confidence interval [CI], [1605–2641]; p < 0.001). In addition, CWAT-based
interventions in these populations significantly decreased systolic blood pressure (− 3.79 mm Hg; 95% CI: [− 4.53, −
3.04] mm Hg; p < 0.001), waist circumference (− 0.99 cm; 95% CI: [− 1.48, − 0.50] cm; p < 0.001) and low-density
lipoprotein cholesterol concentration (− 5.70 mg/dl; 95% CI: [− 9.24, − 2.15] mg/dl; p = 0.002).
(Continued on next page)
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Conclusion: CWAT-based interventions increase physical activity and have beneficial effects on important health-
related outcomes such as systolic blood pressure, waist circumference and LDL cholesterol concentration in
patients with chronic diseases.
Keywords: Activity tracker, Physical activity, Cardiometabolic health, Chronic disease
Summary box
What is already known?
 Physical inactivity is one of the major contributing
factors for the development of chronic diseases and
highly correlated with mortality and hospitalization
 Consumer wearable activity trackers have
predominantly been applied in the sports
community for self-monitoring sport/training
performance-related parameters
What are the new findings?
 Consumer wearable activity tracker-based interven-
tions increase physical activity
 The increased number of steps could result in an
improvement of the general health and a reduction
of all-cause mortality in people with chronic diseases
Introduction
Chronic diseases such as chronic respiratory diseases, type
2 diabetes mellitus (T2DM), cardiovascular diseases
(CVD) and cognitive disorders are an important public
health concern worldwide [1]. In fact, recent data indicate
that the prevalence of chronic diseases has increased con-
siderably to 40 million global deaths in 2015. As a result,
chronic diseases now are the leading cause of mortality
worldwide and as such constitute one of the most import-
ant challenges for the twenty-first century [2, 3].
Physical inactivity is one of the major contributing fac-
tors for the development of chronic diseases and is
highly correlated with mortality and hospitalization [4,
5]. On the other hand, it is well known that increased
physical activity has significant health benefits and is as-
sociated with the prevention and delayed onset of many
chronic diseases [4, 6]. Given the important role of phys-
ical activity in the prevention and management of
chronic diseases, it is crucial to promote physical activ-
ity. Hence, to date, a multitude of physical activity
recommendations and many supervised training inter-
ventions and rehabilitation programs are available to en-
courage physical activity in the global population [7, 8].
Nevertheless, a recent report from the World Health
Organization (WHO) indicates that 23% of the adult and
80% of the adolescent population is still physically in-
active [9]. Here, very poor long-term compliance to ad-
equate physical activity and a healthy lifestyle appears to
be one of the main factors explaining this discrepancy.
Consequently, any strategy that improves long-term ad-
herence to adequate daily physical activity and a healthy
lifestyle, especially in a population with chronic diseases,
is worthwhile investigating. The use of structured behav-
iour change interventions (e.g. telephone counselling,
group sessions, provision of written information mate-
rials or individual education sessions) is reported to be
effective in increasing physical activity, subsequently
leading to a reduced progression of chronic diseases
[10–13]. In addition, although Bravata et al. showed that
goal setting may be a key motivational factor for increas-
ing physical activity, this conclusion was based on obser-
vational studies and healthy individuals [14]. However,
these strategies are often resource-intensive and time-
consuming, factors that limit long-term adherence and
usually not feasible in routine clinical care [15]. In this
respect and following the recent use of pedometer and
accelerometer-based remote monitoring of physical ac-
tivity in patients with chronic diseases, consumer wear-
able activity trackers (CWATs) may be an alternative
strategy to increase physical activity levels. CWATs are
electronic devices used for monitoring and recording
daily physical activity, although nowadays the term is
also used for wearable fitness gadgets. These CWATs
are consisted of pedometers (e.g. Omron and Yamax),
which provide direct feedback on the level of physical
activity in terms of number of steps per day, and activity
trackers (Polar, Fitbit, Garmin and Apple Watch) which
often include goal setting and can monitor physical ac-
tivity and fitness related metrics including the amount
and intensity of physical activity, sedentary behaviour
and heart rate. Initially, CWATs have predominantly
been applied in the sports community for self-
monitoring sport/training performance-related parame-
ters [16–18]. To date, they are widely used to quantify
physical activity and monitor fitness. Possibly, the self-
management, motivational and goal setting properties of
these commercially available devices may also help pa-
tients with chronic diseases to better adhere to long-
term physical activity under free-living conditions in a
home-based setting. Surprisingly and despite the wide-
spread use of these wearables, their feasibility and
efficacy on physical activity (compliance) and cardiomet-
abolic health including anthropometric measurements,
systemic blood pressure, lipid profile and glycemic index,
especially in patients with chronic diseases, is not fully
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clear. Although recent reviews have shown that CWATs
have potential to increase physical activity, they included
only one type of chronic disease [19, 20] or solely pe-
dometers [14, 21]. In addition, conclusions are not based
on randomised controlled trials [14, 22] and most of re-
views did not (or partly) report a cardiometabolic risk
profile [15, 19, 20, 23].
Therefore, this study aims to systematically evaluate
the efficacy of CWAT-based interventions, as CWATs
being either the primary components of an intervention
or as part of a multi-component intervention, to pro-
mote physical activity levels and cardiometabolic health
in populations with chronic diseases including chronic
respiratory diseases, T2DM, CVD, overweight/obesity,
cognitive disorders or sedentary older adults. A better
understanding whether CWATs improve adherence to
physical activity and hereby affect cardiometabolic health
outcomes may help to increase the efficacy and quality
of health care in populations with chronic diseases.
Methods
This systematic review, including an explorative meta-
analysis, was registered in the PROSPERO inter-
national prospective register of systematic reviews
(registration number: CRD42019124126) and was per-
formed in accordance with The Preferred Reporting
Items for Systematic reviews and Meta-Analysis
(PRISMA) statement [24, 25].
Data sources and search strategies
Studies were collected (from inception until March
2019) using computer-based searches in the PubMed,
Embase, Web of Science, The Cochrane Central Register
of Controlled Trials (CENTRAL) and CINAHL elec-
tronic databases. Database specific search strategies were
developed with the guidance of a professional clinical li-
brarian. The database searches were performed using
four main concepts: chronic diseases or sedentary older
adults, CWATs, behaviour change and cardiometabolic
health measures. For each main concept relevant related
terms and keywords were included in the sensitive
search (details presented in Appendix I). The systematic
search was limited to the English, German and Dutch
language.
Eligibility criteria
Inclusion criteria to select studies were: 1) Study popula-
tion: adult (aged 18 or older) patients with main chronic
diseases including chronic respiratory diseases, T2DM,
CVD, overweight/obesity and cognitive disorders, or sed-
entary older adults (> 55 years; high risk population); 2)
Types of studies: peer-reviewed randomised controlled
trials regarding a CWAT-based behaviour change inter-
vention compared to a control intervention or usual care
comparison group. The behaviour change intervention
could be a CWAT-only intervention or a multi-
component intervention consisting of a CWAT in com-
bination with lifestyle data platforms, applications to
change lifestyle behaviour or coaching sessions. In
addition, physical activity should be measured object-
ively; 3) Primary outcome: physical activity expressed in
number of steps per day and 4) Secondary outcomes:
cardiometabolic health outcomes including physical fit-
ness, exercise capacity, anthropometric measures (body
weight, body mass index (BMI), waist circumference and
percentage fat mass), systolic and diastolic blood pres-
sure (BP), resting heart rate, lipid profile (blood total
cholesterol, high-density lipoprotein (HDL) cholesterol,
low-density lipoprotein (LDL) cholesterol and triglycer-
ide concentrations), blood glycated haemoglobin con-
centration (HbA1c) and the fasting glucose and insulin
concentration. Studies that included dietary interven-
tions or had an intervention duration of less than 6
weeks were excluded.
Study selection
Studies were independently screened in three different
steps by two authors (W.M.A.F. and J.S.). Firstly, dupli-
cates were removed using the de-duplication method
from Bramer et al. [26] and a first selection was per-
formed based on titles and abstracts to identify relevant
studies. Then, articles were screened and systematically
excluded when they did not meet the pre-specified in-
clusion criteria. In addition, reviews, editorials, congress
abstracts and validation studies were also excluded. Dis-
agreements between authors were resolved by consensus
with a third reviewer (B.O.E).
Data extraction
Data were independently extracted by two of the re-
viewers (W.M.A.F. and J.S.). Data extraction was per-
formed with the aid of a predesigned data collection
form, adapted from the extraction form of the Cochrane
Collaboration (Appendix II). For each study, the re-
viewers extracted information with respect to study
characteristics (type of study, population description, fo-
cused disease or condition, types of outcome measures);
study participants (sample size, demographics); methods
(study aim, study design, intervention duration, type and
frequency, CWAT type, blinding, amount of intervention
groups, number of included participants, dropouts and
the number of individuals that were randomised and an-
alyzed); outcome variables (outcome definition, unit of
measurement, time points measured and reported, stat-
istical method used). If a study consisted of two or more
study arms of which one of the intervention arms did
not meet the inclusion criteria, data were only extracted
from the study arms that met the inclusion criteria.
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Continuous data including, means, standard deviations
and the sample size numbers were extracted. When
mean differences were not available, authors of the in-
cluded studies were contacted to request additional data.
Without availability of standard deviations, measures of
variance were estimated from the standard error of a
mean, confidence intervals or p-values according to the
Cochrane Handbook for Systematic Reviews of Interven-
tions the Cochrane Collaboration (Version 5.2, chapter
7) [27]. In addition, when data were presented as median
and interquartile range, the mean and standard deviation
were estimated using the formula from Hozo et al. [28].
Blood parameters were converted to the same unit (from
mmol/l to mg/dl), including triglycerides (divide by
0.0112), total cholesterol, HDL cholesterol, LDL choles-
terol (divide by 0.02586) and glucose (divide by 0.05551)
concentration [29].
Study quality assessment
The risk of bias of the included studies was assessed by
one reviewer (W.M.A.F.) as recommended by Higgins
et al. (Cochrane ‘Risk of Bias’ assessment tool, the
Cochrane Collaboration). Here, the following methodo-
logical criteria were assessed: sequence generation, allo-
cation concealment, blinding of participants, personnel
and outcome assessors, incomplete outcome data, select-
ive outcome reporting and other potential threats to val-
idity [27]. Each of these criteria were judged and
classified as ‘low risk’, ‘high risk’ or ‘unclear risk’ of bias.
Statistical analysis
Statistical analyses were performed using R version 3.6.0
(The R foundation for Statistical Computing, Wien,
Austria) [30]. The mean differences (post-intervention
parameter – pre-intervention parameter) with 95% con-
fidence intervals were calculated and pooled effect esti-
mates were obtained using a random-effects model due
to the large heterogeneity among the studies (different
populations, age, intervention type). Some studies used
multiple intervention groups, or the same intervention
and control groups were measured at multiple time in-
tervals. Therefore, an extension of the standard meta-
analysis models was applied on these data, in order to
take correlations of effect estimates coming from the
same study into account. The influence of population
(age, sex proportion [% male] and populations with vari-
ous chronic diseases) and study characteristics (interven-
tion type [only CWAT use, or a CWAT in combination
with behaviour change strategies including goal setting,
telephone support and/or individual or group counsel-
ling] and intervention duration) on the intervention ef-
fect was evaluated using a mixed effects meta-regression
analysis. Here, the effects of these covariates were stud-
ied as fixed effects in the model. Tests for overall effect
as well as pairwise comparisons among populations were
performed. For the latter, adjustments for all other ef-
fects and corrections for multiple comparisons were
used. Studies with missing values regarding the covari-
ates were not included into the analysis. The beta esti-
mate refers to the change in number of steps per day for
a unit change in the characteristics. Sensitivity analyses
were performed to assess heterogeneity of the studies
and to evaluate the robustness of the results. Each study
was individually removed to evaluate the effect of that
study on the summary estimates. Publication bias was
assessed using funnel plots and the Egger test (Appendix
III). The effect of heterogeneity of each summary effect
size was quantified using a chi-squared test and the I2
statistic, in which the boundary limits 25, 50, and 75%
were designated as a low, moderate, and high heterogen-
eity value [31].
Results
The search strategy identified 13,688 potentially relevant
studies of which 8147 after deduplication (Fig. 1).
Thirty-five full-text articles fulfilled the inclusion criteria
and were included in qualitative (n = 35) and quantita-
tive (n = 33) synthesis (Table 1.). Studies included were
published over a 14-year period from 2004 to 2018. All
studies were written in English and performed in 13 dif-
ferent countries predominantly originating from the
United States (n = 10). The included studies consisted of
populations with various chronic diseases including
chronic respiratory diseases (n = 7) [32–38], impaired
glucose tolerance or T2DM (n = 12) [39–50], CVD (n =
6) [51–56], overweight/obesity (n = 3) [57–59], cognitive
disorders (n = 1) [60] and sedentary older adults (n = 6)
[61–65].
Risk of bias
Among the 35 included studies, several increased risks
of bias were assessed. Fifteen studies met five (n = 5) [37,
42, 57, 59, 65] and four (n = 10) [18, 33, 38, 41, 49, 53,
55, 58, 64, 66] of the six risk of bias criteria. Eighteen
studies met three criteria [32, 34–36, 39, 40, 43–45, 47,
50–52, 56, 60–63] and two studies met only two criteria
[48, 54]. Although all studies reported appropriate ran-
dom sequence allocation, insufficient information re-
garding the procedures used to conceal the allocation of
the different trial arm(s) was provided in 21 of the 35
studies (Fig. 2). The largest risk of bias was with regard
to the performance bias (lack of blinding of participants
and personnel) and detection bias (minimal blinding of
those assessing outcomes). All included studies were un-
able to blind the participants and the study personnel/
physicians (n = 18) or to adequately report blinding (n =
17). Only eight studies blinded the outcome assessors,
whereas the majority of the studies did not adequately
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COPD (62 ± 1a years;
sex m/f: 102/53)
64 30 78 I: Goal setting, motivational
interviewing techniques (five individual
30 min counselling sessions) and







77 C: Usual care
Araiza
2006
T2DM (50 ± 10 years) 6 0 15 I: Pedometer use and instructed to
walk 10.000 steps/day on 5 or more




























15 C: Pedometer use and instructed to
maintain normal activity habits
Armit 2009 Sedentary older
adults (50–59 years:
n = 78, 60–70 years:
n = 58; sex m/f: 40/
51)
12 0 46 I: Physical activity advice provided
during a 30 min behaviour change
counselling session (Transtheoritical
model) and three follow-up telephone












45 C: Usual care (3-5 min of brief verbal
physical activity advice and written
information)
Baker 2008 Overweight/Obesity
(49.3 ± 8.8 years; sex
m/f: 63/16)
12 20 39 I: Pedometer-based walking program
with consultations based on the Trans-
theoretical Model of exercise behav-
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40 C: Maintain usual activity levels
Bjorgaas
2008
T2DM (58.9 ± 10.5
years; sex m/f: 31/17)
26 31 23 I: Pedometer use, goal setting, physical
activity calendar, encouraged to




















25 C: Encouraged to increase daily time
spent walking
Bond 2014 Overweight/Obesity
(46.0 ± 8.9 years; sex
m/f: 10/65)
6 6 40 I: Individual face-to-face counseling
sessions (6 sessions lasted 30–45min)
based on theoretical constructs from
the Transtheoretical Model, Theory of
Planned Behaviour, Social Cognitive
Theory, and Self-Determination Theory;
goal setting, pedometer use, problem




35 C:Standard preoperative care. Surgeons
and members of the surgical team
advised
participants to adopt an active lifestyle




CVD (63.8 ± 10.8
years; sex m/f: 83/27)
26 26 55 I: Pedometer use, step calendar, four
telephone calls, behavioural
counselling, goal setting, generic














Asthma (45.9 ± 16.7
years; sex m/f: 5/32)
12 19 20 I: Individual standardized educational
session, Pedometer use, step based
physical activity prescription, goal
setting (steps taken during the











adults (72.9 ± 8.8
years; sex m/f: 32/
115)
12 14 79 I: Behaviour change counselling
session (Social cognitive theory),
pedometer use, goal setting, select
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Intervention CWAT type Outcome
parameter
counts, review pedometer usage and
discuss procedures for keeping a step
calendar and monthly group sessions




COPD (64.1 ± 11.1
years; sex m/f: 9/12)
10 24 10 I: Behaviour change counselling












n = 6, 55–75 years:
n = 35; sex m/f: 28/
13)
12 10 20 I: cognitive-behavioural group



















21 C: Usual care and one single group
education on the effects of physical
activity on diabetes care
De Greef
2011 (1)
T2DM (67.4 ± 9.3
years; sex m/f: 47/20)
12 4 21 I1: Pedometer and diary use, goal
setting, three 90min group
counselling sessions (based on the
cognitive behavioural therapy, the
Diabetes Prevention Program, the First
Step Program and motivational
















22 I2: Pedometer and diary use, goal
setting, three individual 15 min face-
to-face consultations with a clinical
psychologist




T2DM (62 ± 9 years;
sex m/f: 64/28)
26 4 60 I: Face-to-face session (based on the
cognitive behavioural therapy, the Dia-
betes Prevention Program, the First
Step Program and motivational inter-
viewing), pedometer and diary use, 24-










T2DM (54.2 ± 11.6
years sex m/f: 18/35)
12 38 27 I: Diabetes Self-Management Education
Program, Manpo-Kei book; pedometer
use, record pedometer readings ac-
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CVD (62.3 ± 8.3 years;
sex m/f: 19/6)
12 22 16 I: CWAT use, exercise prescription by
daily step count, health coaching
(health related recommendations,
planning, motivation and sending
educational material via email and text
messages)





9 C: Usual care
Engel 2006 T2DM (62.4 ± 7.7
years; sex m/f: 28/26)
26 7 24 I: Coaching (Diabetes-related
education, goal setting, supportive/
motivational strategies, behaviour
change strategies and psychosocial
support by telephone or face-to-face















30 C: Coaching (Diabetes-related
education, goal setting, supportive/
motivational strategies, behaviour
change strategies and psychosocial




COPD (62.2 ± 8.6
years; sex m/f: 21/14)
12 10 18 I: Customized exercise counselling






17 C: Usual care
Houle 2011 CVD (58.5 ± 8.5 years;
sex m/f: 51/14)
52 22 32 I: Pedometer use, diary, physical
activity, goal setting (target of 3000
steps per day increment in physical
activity counselling (social cognitive



















33 C: Usual care
Kaminsky
2013
CVD (56.0 ± 9.2 years;
sex m/f: 14/4)
8 36 10 I: Recommended to obtain a minimum
of 30–40min/day moderate-to-
vigorous physical activity on days they
did not attend cardiac rehabilitation,
daily step count goals to increase by






8 C: Usual care
Kawagoshi
2015
COPD (74.6 ± 8.4
years; sex m/f: 24/3)
52 31 12 I: Multidisciplinary home-based phys-
ical rehabilitation program, pedometer
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Intervention CWAT type Outcome
parameter





(45.4 ± 10.0 years; sex
m/f: 81/99)
12 16 58 I1: Pedometer use, weekly care calls
from trained coaches (information
about overweight or obesity-related
diseases like type 2 diabetes, healthy
diet, physical activity, and coping strat-
egies for lifestyle changes), participants
were motivated to achieve individual






















61 I2: Pedometer use
61 C: Routine care
Kooiman
2018
T2DM (56.4 ± 11.3
years; sex m/f: 38/34)
13 8 40 I: Usual care, activity tracker and access














32 C: Usual care
Mendoza
2015
COPD (68.7 ± 8.5
years; sex m/f: 62/40)







50 C: Counselling to increase physical
activity (to walk at least 30 min/day)
Nolan 2017 COPD (68 ± 9 years;
sex m/f: 110/42)
26 26 76 I: Usual care (physical rehabilitation
programme), pedometer use, goal











adults (67.3 ± 6.3
years; sex m/f: 135/
35)
12 24 51 I1:Pedometer use, given the goal to
increase daily step count by 10% each
week, when 10.000 steps per day were
reached they were instructed to






62 I2: Pedometer use, interactive website
with key strategies to increase PA
systematically in older adults including
education and goal setting, self-
regulation, and frequent feedback and
rewarding, incentives
57 C: Maintain usual activity levels
Suboc Sedentary older 12 6 41 I1: Pedometer use, goal setting (10% Omron HJ- Physical activity:
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Intervention CWAT type Outcome
parameter
2014 [1] adults (63.1 ± 7.3
years; sex m/f: 71/36)
























36 I2: Pedometer use combined with
interactive website intervention
(frequent feedback, motivational
messages, self-regulation, goal setting,
education and practice in realistic be-
havioural change strategies, rewarding)




adults (63.0 ± 7.3
years; sex m/f: 35/67)
12 6 35 I1: Pedometer use, goal setting (10%



















28 I2: Pedometer use combined with
interactive website intervention
(frequent feedback, motivational
messages, self-regulation, goal setting,
education and practice in realistic be-
havioural change strategies, rewarding)
39 C: Maintain usual activity levels
Ter Hoeve
2018
CVD (59.0 ± 8.5 years;
sex m/f: 260/64)
64 34 161 I: Pedometer use, 3 face-to-face group
PA counseling sessions consisted of in-
formation about health behavior, self-
monitoring, goal setting, feedback,






163 C: Usual care
Tudor-
Locke 2004
T2DM (52.7 ± 5.2
years; sex m/f: 26/21)
16 22 24 I: First Step behavioural modification
program: Behaviour modification
program based on the theoretical
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Intervention CWAT type Outcome
parameter
support, the common clinical practices
of goal setting, pedometer use and a























23 C: Usual care
Van Dyck
2013
T2DM (62 ± 9 years;
sex m/f: 63/29)
52 0 60 I: Pedometer use, face-to-face session,



























disease (72.3 ± 5.2
years; sex m/f: 12/9)
16 43 9 I: Pedometer use, goal setting
(increase goal steps 20% each week
and maintaining in weeks 7 and 8), bi-
weekly phone calls to encourage phys-
ical activity
Fitbit Zip Physical activity:
- Steps/day
12 C: Masked pedometers
Vogel 2017 CVD (62.8 ± 9.5 years;
sex m/f: 29/0)
12 0 13 I: Pedometer use, goal setting Polar loop Cardiometabolic:
- Work rate




adults (75.7 ± 6.8
years; sex m/f: 42/40)
26 6 40 I: Pedometer-based behavioural
change program consisted of goal set-
ting (increase daily steps by 10% each






42 C: Maintain usual activity levels
Yates 2009 Impaired glucose
tolerance (65.5 ± 9.0
years; sex m/f: 37/21)
52 18 29 I: Group-based education program
(PREPARE program), pedometer use,
goal setting (increase activity levels by







29 C: Usual care
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report blinding of the outcome assessors (n = 22). Most
of the studies provided complete outcome data (n = 31),
whereas three studies had a high risk of attrition bias
[38, 54, 60] due to incomplete outcome data and only
one study reported insufficient information [48].
Study characteristics
The CWAT-based interventions evaluated in the in-
cluded studies varied considerably in intervention dur-
ation (mean ± SD; 22 ± 17 weeks; range: 6–64 weeks). In
addition, various studies evaluated the effect of a multi-
component intervention on physical activity and cardio-
metabolic health, such as CWAT use with individual
counselling and goal setting (n = 10) and CWAT use
with group counselling (n = 3) [41, 49, 50]. The majority
of the interventions consisted of CWAT use and individ-
ual counselling (n = 22) of which five interventions also
used additional telephone calls [48, 51, 59–61]. Control
conditions varied between studies and consisted of usual
care (n = 21) [32, 34–36, 38, 41–43, 46–50, 52–56, 58,
59, 61], maintaining normal physical activity levels (n =
7) [39, 57, 62–66], encouragement to increase daily
physical activity (n = 2) [37, 40], generic information bro-
chures (n = 1) [51], education sessions (n = 2) [33, 44],
coaching sessions (n = 1) [45] and one control group
wore masked CWAT devices (n = 1) [60]. Furthermore,
the average dropout rate among the studies was 17%
(range: 0–43%) of which four studies had a 100% partici-
pants completion rate.
Population characteristics
The included studies evaluated a total of 2858 partici-
pants (intervention: n = 1567; control: n = 1291) of which
529 participants with chronic respiratory diseases (492
with chronic obstructive pulmonary disease; COPD), 704
participants with T2DM, 571 participants with CVD,
334 participants with overweight/obesity, 21 participants
with Alzheimer’s disease and 699 sedentary older adults.
Their mean age was 61.3 ± 7.3 years (range: 45.4–75.7
years) whereas two studies did not provide information
of the average population age [41, 61]. Overall, 60%
(range: 13–89%) of the participants were male and one
study included only male participants. Twenty-five stud-
ies reported daily step counts and most of the partici-
pants in the intervention (5105 ± 2591 steps/day; range:
2031–9003 steps/day) and control (5149 ± 2751 steps/
day; range: 2334–7539 steps/day) groups were relatively
physically inactive at baseline.
Physical activity
Thirty-three of the studies included data on mean differ-
ences of physical activity, expressed as steps per day, and
were included in the meta-analyses. Overall, participants
with chronic diseases assigned to an intervention group
significantly increased their physical activity (step count)
by 2123 steps per day more than individuals from con-
trol groups (95% confidence interval [CI]: [1605, 2641]
steps/day; p < 0.001). Subgroup analyses showed a sig-
nificantly increased physical activity above baseline in all
groups with a chronic disease, including chronic respira-
tory diseases (+ 1314 steps/day; 95% CI: [203, 2426]
steps/day; p = 0.020), T2DM (+ 2693 steps/day; 95% CI:
[1804, 3581] steps/day; p < 0.001), CVD (+ 1300 steps/
day; 95% CI: [370, 2230] steps/day; p = 0.006), over-
weight/obesity (+ 2405 steps/day; 95% CI: [1232, 3577]
steps/day; p < 0.001) and sedentary older adults (+ 2568
steps/day; 95% CI: [1396, 3740] steps/day; p < 0.001),
compared to the control groups Fig. 3. However, these
results were statistically heterogeneous with respect to
the overall effect (Q = 375.2, p < 0.001; I2 = 92) as well as
the results from individual subgroups including chronic
respiratory diseases (Q = 75.9, p < 0.001; I2 = 97), T2DM
(Q = 95.3, p < 0.001; I2 = 86), overweight/obesity (Q = 4.4,
p = 0.037; I2 = 77) and sedentary older adults (Q = 58.9,
p < 0.001; I2 < 82). In addition, significant publication
bias was found in subgroup analyses for patients with
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tion program (PREPARE program), ped-
ometer use, goal setting (increase
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CVD (p = 0.012), overweight/obesity (p = 0.037) and
sedentary older adults (p = 0.004). Since only 1 study
was found regarding cognitive diseases, this study was
not included into the meta-analysis. No significant
improvement in physical activity was found in pa-
tients with Alzheimer’s disease after an 8-week inter-
vention period.
Association between physical activity and participant and
intervention characteristics
Meta-regression analysis showed that all participant
characteristics were significantly associated with
increased physical activity among individuals from the
intervention groups. With respect to the participant
characteristics, sex proportion (β = 41.0; p = 0.039) and
CWAT users of a younger age (β = − 189.3; p = 0.007)
were significantly associated with a higher increase in
physical activity. In addition, patients with chronic re-
spiratory diseases or CVD had a significantly lower in-
crease in physical activity, compared to other
populations with chronic diseases (p < 0.001). Further-
more, no significant association was found between the
intervention duration (β = − 7.2; p = 0.951), intervention
type (β = − 424.4; p = 0.528) and physical activity.
Fig. 1 Flow diagram of the study selection process
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Physical activity and cardiometabolic health
Participants from the intervention groups significantly
decreased their waist circumference (− 0.99 cm; 95% CI:
[− 1.48, − 0.50] cm; p < 0.001), systolic BP (− 3.79 mm
Hg; 95% CI: [− 4.53, − 3.04] mm Hg; p < 0.001) and LDL
cholesterol concentration (− 5.70 mg/dl; 95% CI: [− 9.24,
− 2.15] mg/dl; p = 0.002) more than individuals from the
control group (Table 2). In addition, both waist circum-
ference (Q = 20.0, p = 0.40; I2 = 12), systolic BP (Q = 7.5,
p = 0.98; I2 < 0.001) and LDL cholesterol concentration
(Q = 9.0, p = 0.44; I2 < 0.001) were all homogeneous re-
sults and no significant publication bias was found. Fur-
thermore, the study by Vogel et al. evaluated changes in
physical fitness after a 6-week post-rehabilitation period
and showed a significant increased peak workload in the
CWAT intervention group (from 185 ± 55 to 192 ± 54W
[+ 27W]; p < 0.001), compared to the control group
(from 186 ± 52 to 169 ± 44W [− 17W]).
Discussion
This review systematically evaluated the efficacy of
CWAT-based interventions to promote physical activity
levels and improve cardiometabolic health in sedentary
older adults and patients with chronic diseases, including
chronic respiratory diseases, T2DM, CVD, overweight/
obesity and cognitive disorders. To the best of our
knowledge, this is the first systematic review and meta-
analysis that evaluates the impact of CWATs on physical
activity and cardiometabolic health in populations with
various chronic diseases. In addition, these results are
solely based on randomised controlled trials and object-
ively measured physical activity (number of steps per
day). In general, individuals with a CWAT increased
their physical activity level and this may be associated
with improvements in cardiometabolic health including
waist circumference, systolic BP and LDL cholesterol
concentration.
Physical activity levels increased by 2123 steps per day.
This is comparable to 20 min or 1.5 km of walking.
These results are consistent with findings from other
meta-analyses showing an increased physical activity
among outpatient adults (+ 2500 steps/day) [14] and pa-
tients with T2DM (+ 1822–2042 steps/day) [21, 22]. In
addition, de Vries et al. showed that behavioural phyical
actvity interventions with an activity monitor increase
physical activity (both steps/day and moderate-to-
vigorous physical activity) in adults with overweight and
obesity [20]. Armstrong et al. found that pedometer-
based physical activity promotion increased steps per
day (+ 1000 steps/day) when it is used as an intervention
alone or alongside pulmonary rehabilitation [67]. These
studies all confirm that a CWAT-only, or included in a
multi-component intervention, have a positive effect in
favor of the interventions groups. Here, Dwyer et al. and
Jefferis et al. both found an association between all-
cause mortality and step count where every increment of
1000 steps per day led to a 6 and 14% risk reduction, re-
spectively [68, 69]. In addition, the NAVIGATOR study,
which consisted of 9000 individuals with high cardiovas-
cular risk or impaired glucose tolerance, has shown that
for every additional 2000 steps/day the risk of developing
cardiovascular events decreased by 10%, T2DM by 5.5%,
and the metabolic syndrome risk score redcued by 0.29
z-score [70–72]. In general, CWAT-users included in
this meta-analysis increased their step count from 5100
steps per day at baseline to 7200 after the intervention
period. Consequently and in accordance with Lee et al.,
who obeserved that hazard ratios of all-cause mortality
declined progressively with higher mean steps per day
until approximately 7500 steps/day after which they lev-
eled in older adult women [73], this could indicate a
substantial reduction in all-cause mortality risk and the
development of chronic diseases. As such, our findings
are relevant for the general population and for those
Fig. 2 Risk of bias graph for included studies (n = 35)
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who cannot participate in high-intensity physical
activities.
Meta-regression analysis showed that both patients
with COPD and CVD exhibited the lowest increase in
physical activity among all populations with chronic dis-
eases included in this systematic review. This might be
due to airflow and cardiac limitations and most of these
studies were performed after a rehabilitation period
where baseline physical activity levels were reduced.
These findings were also found by Amstrong et al., who
showed that COPD patients with greater baseline phys-
ical activity levels (> 4000 steps/day) had greater im-
provements in steps per day. These results can be
confirmed by our results since the baseline physical ac-
tivity levels of COPD patients in our meta-analysis were
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Fig. 3 Forest plot of mean differences of physical activity (steps/day) from CWAT-based behaviour change interventions, compared to control
groups. Abbreviations: CI: confidence interval, I2: the variation in pooled effect size attributable to heterogeneity within that group
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showed no additional effect of behaviour change strat-
egies (goal setting, group counselling, individual counsel-
ling or telephone support) on physical activity levels.
This is in contrast with a systematic review that showed
a positive effect for CWATs, even when interventions
were separated into CWAT-only and multifaceted inter-
ventions [74]. However, a larger effect size for interven-
tions that were multifaceted was found compared to
CWAT-only interventions. This suggests that CWATs
can be effective on their own, but when combined with
other behaviour change strategies, such as telephone
support or group-based counselling, the improvement in
physical activity is greater. However, it must be outlined
that Brickwood et al. only included healthy adults and
there was only a small number of studies in our
meta-regression that included both a CWAT-only and
CWATs as part of a multi-component intervention
group. Therefore, more studies are warranted which
include both a CWAT-only and a multi-component
intervention group. Furthermore, patient characteris-
tics were all independently associated with an in-
creased number of step, which possibly explains the
heterogeneity of the overall effect and subgroup ana-
lyses. For example, the obese population was younger
of age compared to other populations and, as a result,
propably showed a higher increase in physical activity.
Therefore, caution is warranted when interpreting
these results.
The increment of physical activity was associated with
improvements in several cardiometabolic health parame-
ters. The systolic BP was significantly decreased in the
intervention groups. This finding is consistent with pre-
vious systematic reviews with respect to physical activity
and blood pressure among outpatient [14] and healthy
sedentary adults [75, 76]. It has been shown that a
change of − 10mm Hg in systolic BP reduces the risk of
developing CVD by 17% and overall mortality by 13%
[77]. In addition, a decrease in systolic BP of 2 mm Hg is
associated with a reduction of 10% in stroke mortality
and a 7% reduction in mortality originating from CVD
[78]. Furthermore, a significantly reduced LDL cholsterol
concentration was found when physical activity levels
were increased among individuals with CWATs. A
meta-analysis from The Cholesterol Treatment Trialists’
Collaboration showed that with the aid of statins the 5-
year incidence of major vascular events reduced by
about 20% and all-cause mortality by 12% per 40mg/dl
in LDL cholesterol concentration. However, since we
showed a reduction of 6 mg/dl, medication has probably
more beneficial effects rather than increasing physical
activity [79]. In addition, most data regarding physical
activity and serum lipids seem to indicate that regular
physical activity or exercise training does not reduce
LDL cholesterol concentration in a clinically relevant
way [80, 81]. However, it has been suggested that regular
physical activity may change the LDL cholesterol particle
Table 2 Effects of CWAT-based behaviour change strategies on cardiometabolic health including anthropometrics, cardiovascular
health and biochemical parameters









Body weight (kg) 11 582/570 90.6 (18.3) 88.4 (18.3) −0.35 [−0.84, 0.13] 0.15
Body mass index (kg/m2) 16 730/733 30.2 (4.9) 30.5 (5.6) −0.05 [−0.20, 0.11] 0.56
Waist circumference (cm) 13 715/715 103.6 (13.4) 103.3 (14.7) −0.99 [−1.48, − 0.50] < 0.001
Cardiovascular
Systolic blood pressure (mm Hg) 13 655/654 133.1 (20.0) 131.7 (18.2) −3.79 [−4.53, −3.04] < 0.001
Diastolic blood pressure (mm Hg) 12 535/590 77.3 (13.9) 77.4 (12.0) 0.12 [−1.23, 1.46] 0.87
Resting heart rate (bpm) 6 295/320 68.5 (11.6) 67.4 (10.5) −1.92 [−3.96, 0.13] 0.07
Biochemical
HbA1c (%) 11 462/424 7.0 (1.4) 7.1 (1.4) −0.07 [−0.16, 0.01] 0.08
Fasting glucose (mg/dl)a 9 471/431 124.1 (40.1) 116.9 (37.3) −1.67 [−5.82, 2.49] 0.43
Triglycerides (mg/dl)a 8 452/414 151.7 (96.6) 149.0 (103.1) −1.11 [−8.03, 5.81] 0.75
Total cholesterol (mg/dl)a 11 483/459 183.9 (44.2) 187.6 (49.4) −1.48 [−7.48, 4.51] 0.63
HDL cholesterol (mg/dl)a 9 484/448 46.7 (16.1) 48.0 (18.0) 0.29 [−1.13, 1.72] 0.69
LDL cholesterol (mg/dl)a 6 408/364 98.4 (39.8) 102.8 (45.3) −5.70 [−9.24, −2.15] 0.002
Abbreviations: LDL: low-density lipoprotein, HDL: High-density lipoprotein
aBlood parameters were converted to the same unit (from mmol/l to mg/dl), including triglycerides (divide by 0.0112), total cholesterol, HDL cholesterol, LDL
cholesterol (divide by 0.02586) and glucose (divide by 0.05551) concentration
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size, even when total LDL concentrations remain con-
stant [82, 83]. We also found a significantly decreased
waist circumference with the same magnitude (− 1.19
cm; 95% CI: [− 1.79, − 0.59] cm) as found in another
published meta-analysis in which the effect of physical
activity and dietery interventions on waist circumference
was evaluated [11]. De Koning et al. have shown that a
decrease of 1 cm in waist circumference reduces the
relative risk of a CVD event by 2% [84]. In this way,
CWAT devices can improve health related outcomes
which are closely related to CVD.
Several limitations of the included studies were ob-
served. First, studies with relatively small sample sizes
and different intervention durations were included in
the meta-analyses. In addition, this review reflected het-
erogeneous study designs which consisted of multiple
components including CWAT use, goal setting, tele-
phone calls, diary use, individual or group counselling,
different therapists, face-to-face or written motivation
and the frequency of the sessions. Therefore, the inde-
pendent contribution of any of these components, or a
combination of these factors, is difficult to establish.
This probably explains the high heterogeneity of the
physical activity results (Q = 375, p < 0.001; I2 = 92).
However, since clinical and methodological diversity is
always present in meta-analysis statistical heterogeneity
is inevitable. Moreover, Higgens et al. reported that al-
most one third of meta-analyses have moderate to con-
siderable heterogeneity [85]. Secondly, only eleven
studies evaluated physical activty (steps/day) in combin-
ation with one or more of the cardiometabolic risk fac-
tors. In this way, no direct associations between
increased physical acitivities (steps/day) and cardiometa-
bolic risk factors could be made and no minimal amount
of steps per day to improve cardiometabolic health could
be determined. Thirdly, various CWAT devices were
both used to objectively measure physical activity and as
a motivational instrument. As a result, this may affect
the control group by increasing their physical activity by
the thought that they were being monitored. Finally, all
studies only measured physical activity but did not take
into account sedentary time. It has been shown that sed-
entary behaviour is a risk factor for cardiometabilic
health and all-cause mortality, indepently of the amount
of physical activity [86, 87]. Therefore, we recommend
to include sedentary time, next to physical activity, in fu-
ture studies.
Conclusion
These results suggest that populations with chronic dis-
eases significantly increase physical activity using
CWATs only, or as part of a multi-component interven-
tion, and improve their cardiometabolic health such as a
reduced waist circumference, systolic BP and LDL chol-
esterol concentration.
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